Pediatric low-grade glioma models: advances and ongoing challenges

Area of Science:

• Pediatric neuro-oncology
• Cancer genomics
• Translational research

Background:

• Pediatric low-grade gliomas (PLGGs) are the most frequent brain tumors in children.
• While many PLGGs are curable, treatment resistance and long-term side effects remain significant challenges.
• Tumor heterogeneity complicates clinical trials and therapeutic development for PLGGs.

Purpose of the Study:

• To review molecular and genetic alterations in pediatric low-grade gliomas.
• To discuss various preclinical models developed for different PLGG subtypes.
• To summarize advances, therapeutic implications, and challenges in PLGG preclinical modeling.

Main Methods:

• Literature review of molecular alterations in pediatric low-grade gliomas.
• Analysis of existing preclinical models for PLGGs.
• Synthesis of scientific advances and therapeutic implications from preclinical studies.

Main Results:

• Advances in sequencing have elucidated the molecular landscape of PLGGs.
• Preclinical models are crucial for understanding disease mechanisms and testing therapeutics.
• Challenges in generating and utilizing PLGG models include tumor microenvironment and genetic heterogeneity.

Conclusions:

• Preclinical models are essential for improving therapeutic outcomes in pediatric low-grade gliomas.
• Addressing the limitations of current models is critical for future research.
• Continued development of robust preclinical models will accelerate the discovery of effective treatments for pediatric low-grade gliomas.